Zobrazeno 1 - 10
of 102
pro vyhledávání: '"B, Susskind"'
Autor:
Douglas M. Smith, Christopher F. Bryan, Arthur B. Eisenbrey, B. Susskind, Alan M. Luger, Herbert F. Polesky, Deborah A. Sesok-Pizzini
Publikováno v:
Transplantation. 82:733-736
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1a43cecb08fb340f02182668a353d40
https://doi.org/10.1097/01.tp.0000230311.91869.75
https://doi.org/10.1097/01.tp.0000230311.91869.75
Autor:
Stephen M. Katz, P Pryzbylowski, I Buyse, J. Ruth, S Warnell, Kahan Bd, Scott A. Gruber, Ronald H. Kerman, C. T. Van Buren, B. Susskind
Publikováno v:
Transplantation. 68:1855-1858
Background. At our transplant center, primary recipients of either a haplo-identical (haplo-ID) living related (LRD) or a cadaveric (CAD) donor renal allograft are transplanted after a negative donor-specific IgG anti-human globulin (AHG) cross-match
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af2def0374030948320970d1a4939628
https://doi.org/10.1097/00007890-199912270-00007
https://doi.org/10.1097/00007890-199912270-00007
Autor:
B. Radovancevic, O.H. Frazier, B. Susskind, P Przybylowski, M Balogna, C. T. Van Buren, Stephen M. Katz, Ronald H. Kerman, Kahan Bd
Publikováno v:
Transplantation. 67:258-262
Background. At our transplant center, cardiac allograft recipients undergo transplantation following a negative IgG anti-human globulin (AHG) crossmatch (XM). Flow cytometry crossmatching (FCXM) is a more sensitive XM procedure than the AHG XM proced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64149972fba8e63c395a3269bb5c2f49
https://doi.org/10.1097/00007890-199901270-00012
https://doi.org/10.1097/00007890-199901270-00012
Autor:
C. T. Van Buren, B. Susskind, A Bayat, R. Nelson, Minh Dang, Ronald H. Kerman, Kahan Bd, J. Gregory, Stephen M. Katz, T. La
Publikováno v:
Transplantation. 66:1823-1826
Background. Disadvantages inherent to complement-dependent cytotoxicity cross-match (CDC XM) methods are the requirements for complement and viable target cells, detection of antibodies (Abs) against non-HLA antigens, and subjective scoring. Cross-St
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::275905c4b8278898e1eea751172558e4
https://doi.org/10.1097/00007890-199812270-00042
https://doi.org/10.1097/00007890-199812270-00042
Autor:
Stephen M. Katz, Ronald H. Kerman, B A Hartwell, Kahan Bd, C. T. Van Buren, B J Browne, B. Susskind, B G Davis
Publikováno v:
Transplantation. 61:205-211
This study correlated overall serum IgA levels in pretransplant (preTx) sera with graft survival. IgA levels, determined by nephelometry, were normally distributed, with a mean level of 255±139 mg/dl and a median of 234 mg/dl in 631 adult primary ki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f02abe5819c80bcbb1f4e6a968b6e86
https://doi.org/10.1097/00007890-199601270-00007
https://doi.org/10.1097/00007890-199601270-00007
Autor:
Prabir Roy-Chaudhury, Amit Govil, Lois J. Arend, E. S. Woodle, Matthew J Everly, Paul Brailey, Evan A. Brown, Rita R. Alloway, G. Mogilishetty, A.H. Rike, M. Cardi, J. J. Everly, Amit D. Tevar, G Wadih, B. Susskind
Publikováno v:
Transplantation proceedings. 41(1)
Background Current antibody-mediated rejection (AMR) therapies (intravenous immunoglobulin, apheresis, rituximab, polyclonal antibodies) do not target the primary antibody producing B cells, that is, the plasma cell. We report the preliminary results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6465c3e8cc2ad08cfe9a5fbc33a6984f
https://pubmed.ncbi.nlm.nih.gov/19249489
https://pubmed.ncbi.nlm.nih.gov/19249489
Autor:
A. Heydari, R. M. Lewis, B. Susskind, Ronald H. Kerman, J. Williams, Barry D. Kahan, Stephen M. Katz, Joel W. Slaton, J. Ruth, C. T. Van Buren
Publikováno v:
Transplantation Proceedings. 29:1451-1453
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cf82fa66e88fc1b26915cc144b2756c
https://doi.org/10.1016/s0041-1345(96)00562-3
https://doi.org/10.1016/s0041-1345(96)00562-3
Autor:
J Coutee, Thomas E. Burns, G. Swies, B Susskind, D Calvert, B Kostro, C Cava-Bartsch, Richard M. Lewis
Publikováno v:
Transplantation proceedings. 33(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3c08d81da7dfb63b00d2241d1703e36
https://pubmed.ncbi.nlm.nih.gov/11543818
https://pubmed.ncbi.nlm.nih.gov/11543818
Autor:
R H, Kerman, B, Susskind, I, Buyse, P, Pryzbylowski, J, Ruth, S, Warnell, S A, Gruber, S, Katz, C T, Van Buren, B D, Kahan
Publikováno v:
Transplantation. 68(12)
At our transplant center, primary recipients of either a haplo-identical (haplo-ID) living related (LRD) or a cadaveric (CAD) donor renal allograft are transplanted after a negative donor-specific IgG anti-human globulin (AHG) cross-match (XM). Testi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f12394760c79a1533d09d78012fb1c2f
https://pubmed.ncbi.nlm.nih.gov/10628764
https://pubmed.ncbi.nlm.nih.gov/10628764
Publikováno v:
Transplantation proceedings. 31(1-2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d1b52c5b51b7608a6f612a6755dcb5
https://pubmed.ncbi.nlm.nih.gov/10083321
https://pubmed.ncbi.nlm.nih.gov/10083321